Sonova stock holds near CHF 200 as results shape the outlook

Published on 09/22/2026 at 12:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock traded at CHF 200.40 on September 21, 2026, within its 52-week range. The latest half-year revenue reached CHF 1.9 billion.

Professional architectural photography of a modern medical technology corporate headquarters building featuring floor-to-ceiling glass facade with structural transparency revealing bright open office floors, surrounded by manicured greenery and a reflecti — Sonova CH0012549785: Modernes Med-Tech-Headquarter mit transparenter Glasfassade, Spiegelbecken und Grünanlagen bei goldenem Abendlicht, Illustration mit AI erstellt.

Sonova (CH0012549785) traded at CHF 200.40 on SIX at the close on September 21, 2026, giving the hearing-care group a clearly dated market reference ahead of the September 22 session. The latest reported half-year revenue was CHF 1.9 billion for the period ended September 30, 2025, while operating profit reached CHF 325.4 million.

Revenue sets the operating base

Sonova's half-year revenue of CHF 1.9 billion represented a 7.8 percent increase from the comparable period, according to the company's investor-relations materials dated November 18, 2025. Operating profit of CHF 325.4 million was 9.4 percent above the prior-year period, giving investors a quantified comparison between sales growth and earnings growth.

The figures point to operating leverage rather than a purely volume-driven expansion. The comparison matters because a larger revenue base only improves the investment case if profit grows at least as quickly as sales.

Stock remains inside its range

The SIX closing price of CHF 200.40 on September 21, 2026, stood between the 52-week low of CHF 172.20 and the 52-week high of CHF 246.80. That range places the share CHF 46.40 below its yearly high and CHF 28.20 above its low, a useful measure of the current trading position without mixing currencies or venues.

Sonova is listed on SIX under the ticker SOON and belongs to Switzerland's SMI index. The stock therefore combines company-specific earnings information with the valuation and risk profile of a major Swiss large-cap healthcare holding.

CHF 200 remains the reference level

Sonova stock closed at CHF 200.40 on SIX on September 21, 2026. The price, the CHF 1.9 billion half-year revenue figure and the CHF 325.4 million operating profit provide the key dated reference points for assessing the shares.